Clinical Trials in Los Angeles

Showing 6281-6300 of 12,794 trials

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients

NCT04754204

To determine the associations among biometric data, arrhythmias, subject-reported symptoms and subject wellness.

Zoll Medical Corporation585 participantsStarted Dec 2020

Bakersfield, California, United States • Long Beach, California, United States • Los Angeles, California, United States +17 more locations

COMPLETEDPhase 2< 1 mile

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00698815

This randomized phase II trial studies pemetrexed disodium and sunitinib malate to compare how well they work when given alone or together as second-line therapy in treating patients with stage IIIB or stage IV non-small cell lung cancer. Drugs used in chemotherapy, such as pemetrexed disodium, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Sunitinib malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. It is not yet known whether pemetrexed disodium and sunitinib malate are more effective when given alone or together in treating non-small cell lung cancer.

Recurrent Non-Small Cell Lung CarcinomaStage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7

National Cancer Institute (NCI)130 participantsStarted Apr 2008

Anaheim, California, United States • Arroyo Grande, California, United States • Baldwin Park, California, United States +126 more locations

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Find Trials by Condition in Los Angeles

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Safety Study of MGA271 in Refractory Cancer

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

Clinical Evaluation of a Daily Wear Silicone Hydrogel Lens

A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Driving Simulation to Assess Non-Sedative Effects of Tolperisone

Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study

Feasibility of Telemedicine Medical Abortion

Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias